Current Report Filing (8-k)
25 April 2022 - 3:01PM
Edgar (US Regulatory)
0001823465
false
0001823465
2022-04-22
2022-04-22
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): April 22, 2022
5:01 ACQUISITION CORP.
(Exact name of Registrant as specified
in its Charter)
Delaware |
|
001-39612 |
|
85-2790755 |
(State or other
jurisdiction of incorporation or
organization) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
|
|
|
|
|
501 Second Street,
Suite 350
San Francisco, CA |
|
|
|
94107 |
(Address of principal executive offices) |
|
|
|
(Zip Code) |
Registrant’s telephone number, including area code: (415) 993-8570
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of
the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Class
A common stock, par value $0.0001 per share |
|
FVAM |
|
The
Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.
Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April
22, 2022, Dr. Martin Mackay, Ph.D., a member of the board of directors (the “Board”) of 5:01 Acquisition Corp. (the “Company”),
notified the Board of his decision to resign from the Board, effective immediately. Dr. Mackay was a member of the Audit Committee. In
connection with and effective immediately following Dr. Mackay’s resignation, the Board appointed Samantha Singer, currently serving
as an independent director of the Company, to the Audit Committee.
Dr.
Mackay’s decision to resign is not based on any disagreement with the Company or its management. He has served on the Company’s
Board since October 2020.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
5:01 ACQUISITION CORP. |
|
|
|
|
By: |
|
/s/ Rebecca L. Lucia |
|
|
|
Rebecca L. Lucia |
|
|
|
Chief Financial Officer |
Date: April 25, 2022 |
|
|
|
501 Acquisition (NASDAQ:FVAM)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
501 Acquisition (NASDAQ:FVAM)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über 501 Acquisition Corp (NASDAQ): 0 Nachrichtenartikel
Weitere 5:01 Acquisition Corp. News-Artikel